Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation (Q40312993)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 June 2006
edit
Language Label Description Also known as
English
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation
scientific article published on 21 June 2006

    Statements

    Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation (English)
    0 references
    0 references
    0 references
    Tonmoy Sharma
    Catherine Reed
    Ingrid Aasen
    21 June 2006
    1-3
    73-83

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit